The Effectiveness of a Mobile Game Intervention in Alcohol Use Disorder (NCT07103785) | Clinical Trial Compass
CompletedNot Applicable
The Effectiveness of a Mobile Game Intervention in Alcohol Use Disorder
Turkey (Türkiye)60 participantsStarted 2024-06-11
Plain-language summary
The aim of this study was to evaluate the effectiveness of a mobile game application targeting attentional bias modification for alcohol stimuli in patients with Alcohol Use Disorder. Attentional bias is the tendency for individuals to pay more attention to some environmental stimuli than others. Previous evidence suggests that attentional bias for alcohol stimuli is associated with severity of drinking and craving. The research questions are as follows;
* Does the developed mobile game application reduce the attentional bias related to alcohol?
* Does the developed mobile game application reduce alcohol craving severity?
* Does the developed mobile game application reduce the severity of alcohol drinking? The researchers will evaluate the effectiveness of the mobile game, which aims to reduce attentional bias to alcohol stimuli, as standard treatment for Alcohol Use Disorder (medical treatment) versus standard treatment + mobile game application group.
Participants,
* Comply with the medical treatment prescribed by the doctor
* Use the mobile gaming app every other day for one month
* Come back in a month for an evaluation
* Be available for a telephone interview three months after the first interview
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being over the age of 18
* Ability to speak and understand Turkish
* Literacy (reading and writing)
* Ability to use a smartphone
* Having received a formal diagnosis of Alcohol Use Disorder (AUD)
* Receiving outpatient treatment and follow-up care for AUD
* Scoring 8 or higher on the Alcohol Use Disorders Identification Test (AUDIT)
Exclusion Criteria:
* Currently experiencing an active psychotic episode
* Currently in a manic or hypomanic episode
* Having a neurodevelopmental or neurocognitive disorder
* Exhibiting symptoms of delirium
* Being under the influence of alcohol or other substances to a degree that negatively affects cognitive functioning
* Having participated as a qualitative data contributor in the initial phase of the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Dot-Probe Task
Timeframe: Average 30 days: measurement before intervention (Time 1), 4 weeks after intervention, immediately after intervention measurement (Time 2)